Latest News
Select the category
Scancell Receives UK MHRA Clinical Trial Authorization for Phase 3 Registrational Trial of iSCIB1+ in Advanced Melanoma
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
Scancell Receives FDA Fast Track Designation for iSCIB1+
Interim Results and Business Update
Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma
Notice of Interim Results and Investor Presentation
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.